- Home
- ALLR vs IXHL Comparison
ALLR vs IXHL Comparison
Compare ALLR & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALLR
- IXHL
- Stock Information
- Founded
- ALLR 2004
- IXHL 2001
- Country
- ALLR United States
- IXHL Australia
- Employees
- ALLR N/A
- IXHL N/A
- Industry
- ALLR Biotechnology: Pharmaceutical Preparations
- IXHL
- Sector
- ALLR Health Care
- IXHL
- Exchange
- ALLR Nasdaq
- IXHL Nasdaq
- Market Cap
- ALLR 15.8M
- IXHL 35.6M
- IPO Year
- ALLR N/A
- IXHL N/A
- Fundamental
- Price
- ALLR $0.94
- IXHL $0.59
- Analyst Decision
- ALLR Strong Buy
- IXHL
- Analyst Count
- ALLR 1
- IXHL 0
- Target Price
- ALLR $9.00
- IXHL N/A
- AVG Volume (30 Days)
- ALLR 367.8K
- IXHL 139.1M
- Earning Date
- ALLR 08-15-2025
- IXHL 09-29-2025
- Dividend Yield
- ALLR N/A
- IXHL N/A
- EPS Growth
- ALLR N/A
- IXHL N/A
- EPS
- ALLR N/A
- IXHL N/A
- Revenue
- ALLR N/A
- IXHL $98,000.00
- Revenue This Year
- ALLR N/A
- IXHL $2,538.49
- Revenue Next Year
- ALLR N/A
- IXHL $249.95
- P/E Ratio
- ALLR N/A
- IXHL N/A
- Revenue Growth
- ALLR N/A
- IXHL N/A
- 52 Week Low
- ALLR $0.61
- IXHL $0.08
- 52 Week High
- ALLR $6.00
- IXHL $3.12
- Technical
- Relative Strength Index (RSI)
- ALLR 47.03
- IXHL 54.83
- Support Level
- ALLR $0.85
- IXHL $0.38
- Resistance Level
- ALLR $1.01
- IXHL $0.42
- Average True Range (ATR)
- ALLR 0.05
- IXHL 0.06
- MACD
- ALLR -0.01
- IXHL -0.00
- Stochastic Oscillator
- ALLR 47.55
- IXHL 88.35
About ALLR Allarity Therapeutics Inc.
Allarity Therapeutics Inc is a clinical-stage, precision medicine pharmaceutical company focused on developing novel anti-cancer therapeutics for patients with high unmet medical needs. The company is actively advancing the development of stenoparib, an orally available, small-molecule inhibitor for patients with advanced recurrent ovarian cancer. It is leveraging its proprietary Drug Response Predictor (DRP) technology to refine patient selection and improve clinical outcomes. The company operates as a single operating and reporting segment (developing a treatment for ovarian cancer) in two geographic areas: Denmark and the United States.
About IXHL Incannex Healthcare Inc.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.